Curasight and Curium announce global partnership for uTRACE® in prostate cancer

Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for man...

May 02, 2023 | Tuesday | News
Aurora Expands Medical Cannabis Portfolio in Germany

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, and a leading manufacturer a...

May 01, 2023 | Monday | News
Brenus Pharma Unveils Preclinical Results for Promising New Cancer Drug STC-10101

Brenus Pharma Announces two groundbreaking presentations on STC-1010, the company's first drug candidate for colorectal cancer (CRC), produced by Brenus Ph...

April 28, 2023 | Friday | News
Hansa Biopharma, Genethon Collaborate on Imlifidase Pre-Treatment for Crigler-Najjar Syndrome Patients with Anti-AAV Antibodies

The collaboration will, in a clinical study, evaluate the safety and efficacy of Hansa's antibody cleaving enzyme imlifidase as a pre-treatment prior ...

April 28, 2023 | Friday | News
Abbott Completes Acquisition of Cardiovascular Systems, Inc.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI's leading atherectomy system prepares vessels for angiopla...

April 28, 2023 | Friday | News
Boehringer Ingelheim Launches Europe's Largest Biotech Development Center

Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date B...

April 27, 2023 | Thursday | News
Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease

European Commission Approval of Opfolda and Commercial Launch of Pombiliti® + Opfolda® Anticipated in 3Q 2023   Upon Approval, Pombiliti + O...

April 27, 2023 | Thursday | News
Roche's Columvi Gets CHMP Nod for Fixed-Duration Use in Diffuse Large B-cell Lymphoma

The recommendation is based on results from the phase I/II NP30179 study, where Columvi given as a fixed course induced early and long-lasting complete r...

April 27, 2023 | Thursday | Regulatory
FineHeart Granted First Two Patents in China for the FLOWMAKER®

These new patents complement the company's strong international portfolio of 20 families and more than 78 patents covering the concept, design, production ...

April 26, 2023 | Wednesday | News
Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows

Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform compa...

April 26, 2023 | Wednesday | News
Forge Biologics Receives QP Declaration for AAV Gene Therapy Manufacturing in Europe

Forge Biologics, a leading manufacturer of genetic medicines, today announced that its manufacturing facility has successfully completed the audits necessa...

April 24, 2023 | Monday | News
Aurisco Expands Oligonucleotide Capacity and Launches New Website

The New State-of-Art OligoPilot 2000™ solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial olig...

April 24, 2023 | Monday | News
FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology and 5-Minute Auto Corrections.

 Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its Mini...

April 22, 2023 | Saturday | News
FUJIFILM Europe Introduces Virtual Scale Solution for Polyp Measurement in Endoscopy.

This survey found that the majority of endoscopists currently find it difficult to measure polyps accurately, with nearly three quarters stating that there...

April 21, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close